Cosmos stock forecast: The stock price opened at $0.50 and created a high of $0.62 as of 28th November. It increased by 35% and in the past day a trader would have generated 235% returns and as a short-term investment for about a month returns could have magnified by 625%.
Cosmos stock forecast: Fundamental analysis
The company owns 3 subsidiaries and they are SkyPharm S.A. (SkyPharm), Decahedron Ltd. (Decahedron), and Cosmofarm S.A. (Cosmofarm). The company has 83.8 million shares outstanding and its market value rounds up to $48.4 million. Earnings per share incurred a loss of $1.8 as per the past twelve-month data. Its PE ratio comes a high valuation of 92.7x.
Cosmos stock forecast: Latest News
SkyPharm to sell its product on an airline - British airways group's Iberia airline provides complimentary digital magazines to its passengers. The strategy here is to let the passenger purchase supplements by using the QR code presented onboard the screen. Ronda, the digital magazine believes that its readers have strong purchasing power with about 600 daily flights. SkyPharm may be able to see a jump in its sales.
Cosmos stock forecast: Latest earnings
- Total revenue posted in Q3 was $12 million whereas in Q2 it was $13.2 million.
- It incurred a net loss of $1.99 million which is a substantial reduction from the Q2 net loss of $18.2 million.
- EBITDA for the same quarter was $0.06 million whereas in Q2 it was $0.25 million.
- Earnings per share were reported with a loss of $0.08 which is an improvement from the 2nd quarter eps in a loss of $0.93.
Also Read: BNGO stock forecast
Cosmos stock forecast: Why did the Cosmos stock price increase?
The stock price opened at $0.50 and created a high of $0.62 as of 28th November. It increased by 35% and in the past day a trader would have generated 235% returns and as a short-term investment for about a month returns could have magnified by 625%. All this would have been possible when the market sentiment for the company is bearish. This is because the contrarian strategy has prevailed here with the help of volume short positions. The short interest change as of 15th November rose by 6.52 million. With many hedge funds and investors shorting the stock, the interest premium for brokers has increased. Consequently, as the premium for brokers increases, they tend to supply more. Due to this reason alone, there is a short squeeze going on in the market for this stock. Meaning, they are unable to close their position as there are no sellers but only buyers in the market directly impacting the stock price to shoot up.
Cosmos stock forecast: About the Company
Cosmos holdings is a nutraceutical company that distributes branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications, and medical devices with about 75 items including vitamins, minerals, and other herbal extracts. It is running its business in the UK and European Union.
-Priyanshi Shah
Note: Crowdwisdom360 collates Predictions and data from all over the net and has no in-house view on the likely trends in the Stocks or Crypto Coins. Please consult a registered investment advisor to guide you on your financial decisions.
Comments
Post a Comment